ALZN icon

Alzamend Neuro
ALZN

11 hedge funds and large institutions have $351K invested in Alzamend Neuro in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

4.43% more ownership

Funds ownership: 0.27% → 4.7% (+4.4%)

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$237K
2
+$56.1K
3
+$53.4K
4
CA
Clearstead Advisors
Ohio
+$26K
5
UBS Group
UBS Group
Switzerland
+$3.05K

Top Sellers

1
-$10
2
-$5
Name Holding Trade Value Shares
Change 		Change in
Stake
DS
1
DRW Securities
Illinois
$217K
Vanguard Group
2
Vanguard Group
Pennsylvania
$51.5K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$49K
CA
4
Clearstead Advisors
Ohio
$23.8K
UBS Group
5
UBS Group
Switzerland
$4.94K
TRCT
6
Tower Research Capital (TRC)
New York
$3.82K
BlackRock
7
BlackRock
New York
$1.04K
Bank of America
8
Bank of America
North Carolina
$88
SS
9
SBI Securities
Japan
$52
HIA
10
Harbor Investment Advisory
Maryland
$2
Citigroup
11
Citigroup
New York
$2
AWM
12
Activest Wealth Management
Florida
–